Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 26 October 2006. doi:10.1136/ard.2004.033829
Annals of the Rheumatic Diseases 2007;66:195-201
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope

Leyla Kazkaz1, Hubert Marotte2, Mayassa Hamwi2, Marie Angélique Cazalis2, Pascal Roy3, Bruno Mougin2, Pierre Miossec2

1 Teshreen Hospital, Damascus, Syria
2 Hospices Civils de Lyon-bioMérieux Research Unit on Rheumatoid Arthritis, Hopital Edouard Herriot, Lyon, France
3 Service de Biostatistiques HCL, Laboratoire de Biostatistique-Santé, Université Claude Bernard Lyon 1, Lyon, France

Correspondence to:
Professor P Miossec
Clinical Immunology Unit, Departments of Immunology and Rheumatology, Hôpital Edouard Hérriot, 69437 Lyon Cedex 03, France; miossec{at}univ-lyon1.fr

Objective: To investigate whether ethnic differences exist in the effect of the shared epitope and selected cytokine gene polymorphisms on the susceptibility and severity of rheumatoid arthritis in Syria (Damascus) and France (Rhône-Alpes area).

Methods: 156 patients with rheumatoid arthritis and 120 healthy controls from Syria were compared with 512 patients with rheumatoid arthritis and 471 healthy controls from France. Shared epitope status, cytokine gene polymorphisms interleukin (IL)-1B +3954, IL-1RN +2018 and tumour necrosis factor {alpha} promoter (–238 and –308) were analysed by enzyme-linked oligosorbent assay. Joint destruction was defined by a right wrist Larsen score >=2. Odds ratios (ORs) were calculated.

Results: In both countries, a dose effect was observed between the shared epitope copy number and rheumatoid arthritis (Syria: OR 1 v 0 copies = 1.6, p = NS; OR 2 v 0 = 15.3, p<0.01; and France: OR 1 v 0 = 2.3, p<0.001; OR 2 v 0 = 7.2, p<0.001). A dose effect was also observed between the shared epitope copy number and joint destruction in Syria (OR 1 v 0 = 2.2, p = NS; OR 2 v 0 = 9.9, p<0.01) and France (OR 1 v 0 = 1.8, p<0.01; OR 2 v 0 = 4.8, p = 0.001). The dose effect of the shared epitope was greater in Syria than in France. Only the –238 tumour necrosis factor {alpha} polymorphism was associated with joint destruction in the Syrian population (p<0.05). However, after adjustment for age, sex, disease duration and rheumatoid factor for severity, this association disappeared.

Conclusion: The frequency of the shared epitope was increased in the French population with rheumatoid arthritis and in controls, but the association between the shared epitope and joint destruction was more pronounced in the Syrian population, with an OR of almost 10 for the homozygotes.

Abbreviations: HLA, human leucocyte antigen; IL, interleukin; PCR, polymerase chain reaction; SNP, single-nucleotide polymorphism; TNF, tumour necrosis factor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • LEE, Y. H., JI, J. D., SONG, G. G. (2009). Association Between Interleukin 1 Polymorphisms and Rheumatoid Arthritis Susceptibility: A Metaanalysis. The Journal of Rheumatology 36: 12-15 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs